Medicine and Dentistry
Patient
100%
Metastatic Breast Cancer
100%
Everolimus
100%
Toxicity
40%
Therapeutic Procedure
40%
Anemia
40%
Thrombocytopenia
40%
Leukopenia
40%
Mean Corpuscular Volume
40%
Cells
20%
Drug
20%
Breast Cancer
20%
Oncologist
20%
Infection
20%
Leukocyte
20%
Clinical Trial
20%
Mixed Model
20%
Adverse Event
20%
Erythrocyte
20%
Immunosuppressive Treatment
20%
Student T Test
20%
Neutrophil
20%
Mechanistic Target of Rapamycin
20%
Hemoglobin Determination
20%
Nonoxinol 9
20%
Lymphocytopenia
20%
Microcytosis
20%
Hemoglobins
20%
Blood
20%
Lymphocyte
20%
Pharmacology, Toxicology and Pharmaceutical Science
Metastatic Breast Cancer
100%
Everolimus
100%
Hemoglobins
100%
Toxicity
50%
Anemia
50%
Thrombocytopenia
50%
Leukopenia
50%
Clinical Trial
25%
Mixed Model
25%
Nonoxynol-9
25%
Drug
25%
Breast Cancer
25%
Infection
25%
Adverse Event
25%
Lymphocytopenia
25%
Mammalian Target of Rapamycin
25%
Microcytosis
25%
Immunology and Microbiology
Everolimus
100%
Breast
100%
Mean Corpuscular Hemoglobin
75%
Time
75%
Mean Corpuscular Volume
50%
Hemocyte
25%
Neutrophil Granulocyte
25%
Sirolimus
25%
Cells
25%
Immunity
25%
Blood Cell Count
25%
Dose
25%
Leukocyte Count
25%
Nonoxynol-9
25%
Lymphocytopenia
25%
Lymphocyte
25%